ELMSFORD, N.Y., Feb. 11, 2014 /PRNewswire/
-- BioScrip®, Inc. (NASDAQ: BIOS) announced today
that the Company will release its 2013 fourth quarter and year-end
financial results on Wednesday, February 26,
2014, after the market closes.
(Logo:
http://photos.prnewswire.com/prnh/20130117/NY44138LOGO )
The Company will host a conference call at 8:30 a.m. Eastern Standard Time (EST) on
Thursday, February 27, 2014.
Richard Smith, President and Chief
Executive Officer, and Hai Tran,
Chief Financial Officer, will conduct the call.
Interested parties may participate in the conference call by
dialing 800-616-4018 (US), or 303-223-2680 (International), 5-10
minutes prior to the start of the call. A replay of the conference
call will be available for two weeks after the call's completion by
dialing 800-633-8284 (US) or 402-977-9140 (International) and
entering conference call ID number 21708103. An audio webcast and
archive will also be available for 30 days under the "Investor
Relations" section of the BioScrip website at www.bioscrip.com.
About BioScrip, Inc.
BioScrip, Inc. is a leading
national provider of infusion and home care solutions. BioScrip
partners with physicians, healthcare payors, government agencies,
hospital systems and pharmaceutical manufacturers to provide
patients access to post-acute care services. BioScrip operates with
a commitment to bring customer-focused pharmacy and related
healthcare infusion therapy services into the home or alternate-
site setting. By collaborating with the full spectrum of healthcare
professionals and the patient, BioScrip provides cost-effective
care that is driven by quality, customer service, and values that
promote positive outcomes and an enhanced quality of life for those
it serves. BioScrip provides its infusion and home care services
from 108 locations across 29 states.
SOURCE BioScrip, Inc.